Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)

Clinical trial NCT02279654 · COMPLETED

Trial details

NCT number: NCT02279654
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndrome

Start date: 2014-12-17
Primary completion: 2022-03-29
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.